Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [IFNG protein results in increased expression of CIITA mRNA] | decreases reaction|increases expression | 14757364
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of CIITA mRNA | increases expression | 17229644
|
C061133 |
Am 80 |
Am 80 results in increased expression of CIITA mRNA | increases expression | 17229644
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CIITA mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of CIITA mRNA | decreases expression | 20458559
|
D001374 |
Azacitidine |
[Azacitidine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]] which results in increased expression of HLA-DRA protein | increases expression|increases reaction | 18829986
|
D001374 |
Azacitidine |
[Azacitidine results in decreased methylation of CIITA promoter] promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] | decreases methylation|increases expression|increases reaction | 18829986
|
C014347 |
decitabine |
decitabine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] | increases expression|increases reaction | 16650406
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CIITA mRNA | decreases expression | 17426115
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CIITA mRNA | increases expression | 17229644
|
D015032 |
Zinc |
Zinc affects the expression of CIITA mRNA | affects expression | 16979875
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.64 | 16889938 17190629 17202136 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D000224 |
Addison Disease |
marker/mechanism |
|
| 18593762 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.32 | 19825857 11798837 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.72 | 16434500 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.75 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.79 | 16325427 16580781 17119284 16410023 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
5.10 | 16916123 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.18 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
marker/mechanism |
|
| |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Am 80 |
5.23 | 16819260 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
5.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.22 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
5.22 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Am 80 |
4.43 | 16484594 |
MESH:C537079 |
Bare lymphocyte syndrome 2 |
marker/mechanism |
|
| |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.60 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
16.39 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.39 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
16.39 | 16197459 16206674 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.90 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.07 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.07 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.07 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.83 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.51 | 11589617 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.42 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.15 | 11135700 14691202 15553829 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.15 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.14 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.28 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.91 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.91 | 16051514 16096774 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
7.91 | 16543248 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.77 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.19 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.83 | 16129372 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.95 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.42 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.73 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.92 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.64 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.64 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.64 | 18981723 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.38 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.01 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.01 | 14991402 9211117 9664655 9224671 9125849 16925845 17551590 9142499 8800419 10589399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
4.01 | 19302082 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.28 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.36 | 16479319 |
MESH:D003967 |
Diarrhea |
|
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
5.08 | 10611417 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.65 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.73 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Am 80 |
5.29 | 16819260 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.38 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.21 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.88 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
4.88 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.70 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.30 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.30 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.73 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.46 | 16904648 |
MESH:D005756 |
Gastritis |
|
Zinc |
5.06 | 17241300 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.11 | 17312396 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
4.07 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
8.20 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.20 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.42 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.98 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.48 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Zinc |
7.48 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
6.03 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.72 | 17241300 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.90 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.21 | 19772884 16221962 19176532 18467677 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.35 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.78 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.31 | 17581917 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.98 | 17994277 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.85 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.07 | 15992940 17551590 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.87 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
3.41 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.59 | 16518626 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
15.66 | 15070760 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
15.66 | 19148494 |
MESH:D007938 |
Leukemia |
|
decitabine |
15.66 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
15.66 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.97 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.54 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.55 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
24.34 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
24.34 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
24.34 | 17236224 18454857 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
24.34 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
9.05 | 20471514 17050201 16467208 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
9.05 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
9.05 | 18460780 18704418 17679729 18206229 19010910 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
9.05 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.73 | 18055864 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.37 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Am 80 |
13.56 | 16819260 16531727 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
13.56 | 16331271 16112521 16330433 19642359 17712046 19035177 17869043 16823087 15622746 17649720 15336539 17107899 9834237 11468182 15748426 12712474 12679006 15213294 12018890 19075265 17217047 11161223 19225113 16966277 16891316 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
13.56 | 17217047 17506722 19225113 12679006 16140955 16891316 17368321 19075265 16331271 16788101 16766008 16823087 17301526 17294898 19029980 17649720 17339181 17107899 16935935 17712046 15748426 17361223 19035177 9834237 19642359 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.55 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.43 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.39 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.39 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.67 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.67 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
2.83 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.48 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
3.80 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.80 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
3.80 | 21224363 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.54 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
3.40 | 12773700 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.84 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.50 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.50 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.64 | 16940565 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.35 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Am 80 |
18.40 | 17229644 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
18.40 | 14977855 15949261 19417148 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
18.40 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
18.40 | 18172295 |
MESH:D009103 |
Multiple Sclerosis |
marker/mechanism |
|
| |
MESH:D009128 |
Muscle Spasticity |
|
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
6.34 | 17220914 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.94 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
18.37 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
18.37 | 18720364 17596541 19805378 17611569 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
18.37 | 16882708 18608210 19157545 19010910 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
18.37 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.16 | 16624393 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
12.57 | 16946489 |
MESH:D009369 |
Neoplasms |
|
decitabine |
12.57 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
12.57 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.57 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.98 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.66 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.66 | 9142499 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
8.21 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.21 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.21 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.04 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
8.98 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.98 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.98 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.35 | 19927285 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.27 | 16144296 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.31 | 17114810 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.94 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Am 80 |
2.20 | 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.20 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.20 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.20 | 12429649 16700911 16517595 16606632 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.79 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Am 80 |
4.14 | 16819260 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.03 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.25 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.57 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.57 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.16 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.68 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.49 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.49 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.49 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
12.80 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
12.80 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.80 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.53 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
10.53 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.20 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.33 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.44 | 20435036 12973940 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.44 | 19087683 17616700 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.84 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
13.73 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
13.73 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.25 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.12 | 16287080 |